Global Point of Care Testing for Infectious Disease Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Point of Care Testing for Infectious Disease Market Insights, Forecast to 2034
Market Analysis and InsightsGlobal Point of Care Testing for Infectious Disease Market
Global Point of Care Testing for Infectious Disease market is expected to reach to US$ 7589 million in 2023, with a positive growth of %, compared with US$ 10280 million in 2022. Backed with the increasing demand from downstream industries, Point of Care Testing for Infectious Disease industry is evaluated to reach US$ 13440 million in 2033. The CAGR will be 10.0% during 2023 to 2033.
Globally, Point of Care Testing for Infectious Disease key companies include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY and Sinocare, etc. Roche, Abbott, LifeScan are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Point of Care Testing for Infectious Disease were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Point of Care Testing for Infectious Disease market and estimated to attract more attentions from industry insiders and investors.
Point of Care Testing for Infectious Disease can be divided into Immunological Test and Pathogen Nucleic Acid Test, etc. Immunological Test is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Point of Care Testing for Infectious Disease is widely used in various fields, such as Hospital, Clinics and Others,, etc. Hospital provides greatest supports to the Point of Care Testing for Infectious Disease industry development. In 2022, global % revenue of Point of Care Testing for Infectious Disease went into Hospital filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Point of Care Testing for Infectious Disease market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Point of Care Testing for Infectious Disease market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Sinocare
Wondfo
Yuwell
Runbio
KHB
Segment by Type
Immunological Test
Pathogen Nucleic Acid Test
Hospital
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Point of Care Testing for Infectious Disease introduction, etc. Point of Care Testing for Infectious Disease Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Point of Care Testing for Infectious Disease
Chapter 13Methodology and Data Sources adopted by MRAResearch![](http://localhost/mraccuracy/images/About Report.webp)
Global Point of Care Testing for Infectious Disease market is expected to reach to US$ 7589 million in 2023, with a positive growth of %, compared with US$ 10280 million in 2022. Backed with the increasing demand from downstream industries, Point of Care Testing for Infectious Disease industry is evaluated to reach US$ 13440 million in 2033. The CAGR will be 10.0% during 2023 to 2033.
Globally, Point of Care Testing for Infectious Disease key companies include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, BioMerieux, ARKRAY and Sinocare, etc. Roche, Abbott, LifeScan are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Point of Care Testing for Infectious Disease were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Point of Care Testing for Infectious Disease market and estimated to attract more attentions from industry insiders and investors.
Point of Care Testing for Infectious Disease can be divided into Immunological Test and Pathogen Nucleic Acid Test, etc. Immunological Test is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Point of Care Testing for Infectious Disease is widely used in various fields, such as Hospital, Clinics and Others,, etc. Hospital provides greatest supports to the Point of Care Testing for Infectious Disease industry development. In 2022, global % revenue of Point of Care Testing for Infectious Disease went into Hospital filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Point of Care Testing for Infectious Disease market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Point of Care Testing for Infectious Disease market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
![](http//localhost/mraccuracy/images/Market%20Recearch%20Graph.jpg)
By Company
Roche
Abbott
LifeScan
Siemens Healthineers
Danaher
Ascensia
BioMerieux
ARKRAY
Sinocare
Wondfo
Yuwell
Runbio
KHB
Segment by Type
Immunological Test
Pathogen Nucleic Acid Test
Segment by Application
Hospital
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Point of Care Testing for Infectious Disease introduction, etc. Point of Care Testing for Infectious Disease Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Point of Care Testing for Infectious Disease
Chapter 13Methodology and Data Sources adopted by MRAResearch
![](http://localhost/mraccuracy/images/About Report.webp)